[go: up one dir, main page]

DE60107707D1 - Mikroben mit einer transkriptionsabbrecher enthaltender dämpfender mutation - Google Patents

Mikroben mit einer transkriptionsabbrecher enthaltender dämpfender mutation

Info

Publication number
DE60107707D1
DE60107707D1 DE2001607707 DE60107707T DE60107707D1 DE 60107707 D1 DE60107707 D1 DE 60107707D1 DE 2001607707 DE2001607707 DE 2001607707 DE 60107707 T DE60107707 T DE 60107707T DE 60107707 D1 DE60107707 D1 DE 60107707D1
Authority
DE
Germany
Prior art keywords
microbes
mutation
transcription
breaker including
including damping
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE2001607707
Other languages
English (en)
Other versions
DE60107707T2 (de
Inventor
Curtiss, Iii
A Tinge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Megan Health Inc
St Louis University
Original Assignee
Megan Health Inc
St Louis University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megan Health Inc, St Louis University filed Critical Megan Health Inc
Application granted granted Critical
Publication of DE60107707D1 publication Critical patent/DE60107707D1/de
Publication of DE60107707T2 publication Critical patent/DE60107707T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DE60107707T 2000-10-12 2001-10-11 Mikroben mit einer transkriptionsabbrecher enthaltender dämpfender mutation Expired - Lifetime DE60107707T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68912300A 2000-10-12 2000-10-12
US689123 2000-10-12
PCT/US2001/031606 WO2002030457A2 (en) 2000-10-12 2001-10-11 Microbes having an attenuating mutation comprising a transcription terminator

Publications (2)

Publication Number Publication Date
DE60107707D1 true DE60107707D1 (de) 2005-01-13
DE60107707T2 DE60107707T2 (de) 2005-12-08

Family

ID=24767139

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60107707T Expired - Lifetime DE60107707T2 (de) 2000-10-12 2001-10-11 Mikroben mit einer transkriptionsabbrecher enthaltender dämpfender mutation

Country Status (7)

Country Link
EP (1) EP1326960B1 (de)
AR (1) AR030882A1 (de)
AT (1) ATE284440T1 (de)
AU (1) AU2002211582A1 (de)
CA (1) CA2463482A1 (de)
DE (1) DE60107707T2 (de)
WO (1) WO2002030457A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1616029A2 (de) * 2003-04-18 2006-01-18 Warnex Research Inc. Oligonukleotide zum nachweis von salmonella-spezies
WO2009025888A2 (en) 2007-05-10 2009-02-26 The Arizona Board Of Regents For And On Behalf Of Arizona State University Regulated synthesis of antigen and/or regulated attentuation to enhance vaccine immunogenics and/or safety
US9040059B2 (en) 2007-10-05 2015-05-26 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting a protective immune response against C. perfringens
WO2010045620A1 (en) 2008-10-17 2010-04-22 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
US9163219B2 (en) 2009-04-14 2015-10-20 Arizona Board Of Regents On Behalf Of Arizona State University Single expression vector for generation of a virus with a segmented genome
GB2483595B (en) 2009-05-22 2017-03-29 The Arizona Board Of Regents For And On Behalf Of Arizona State Univ Recombinant bacterium and methods of antigen and nucleic acid delivery
US9045742B2 (en) 2009-05-29 2015-06-02 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant Edwardsiella bacterium
US9062297B2 (en) 2010-01-13 2015-06-23 The Arizona Board Of Regents For And On Behalf Of Arizona State University Yersinia pestis vaccine
EP2526185A4 (de) 2010-01-22 2013-07-24 Univ Arizona Bakterium mit einer regulierten rfah-nukleinsäure
WO2011150421A2 (en) 2010-05-28 2011-12-01 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium to decrease tumor growth
US9303264B2 (en) 2012-05-18 2016-04-05 The Arizona Board Of Regents For And On Behalf Of Arizona State University Photosynthetic microorganisms expressing thermostable lipase
US9580718B2 (en) 2013-06-17 2017-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Attenuated live bacteria with increased acid resistance and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI9710363B8 (pt) * 1996-07-15 2021-07-06 Us Gov Health & Human Serv partìcula de vìrus sincicial respirátorio recombinante (rsv) infeccioso atenuado, vacina para induzir proteção contra o vìrus sincicial respiratório recombinante (rsv), vetor de expressão, e, método de produção de um vìrus sincicial respiratório recombinante (rsv) infeccioso.
GB9804809D0 (en) * 1998-03-06 1998-04-29 Wallis Timothy S Attenuated salmonella:materials and methods relating thereto

Also Published As

Publication number Publication date
AR030882A1 (es) 2003-09-03
AU2002211582A1 (en) 2002-04-22
ATE284440T1 (de) 2004-12-15
WO2002030457A2 (en) 2002-04-18
DE60107707T2 (de) 2005-12-08
WO2002030457A9 (en) 2003-07-24
EP1326960B1 (de) 2004-12-08
EP1326960A2 (de) 2003-07-16
CA2463482A1 (en) 2003-04-18
WO2002030457A3 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
NO20022155L (no) Glassfiber dannende sammensetninger
DE50113024D1 (de) Werkzeug mit zugeordnetem Schlagwerkzeuggerät
PT1341791E (pt) Imidazoquinolinas substituidas com tioeter
DE60107707D1 (de) Mikroben mit einer transkriptionsabbrecher enthaltender dämpfender mutation
DE50106364D1 (de) Lagerung einer Motor-Getriebeeinheit
DE60111660D1 (de) Tastenfolie
DE60039916D1 (de) Styrol-copolymerzusammensetzung
DE60140070D1 (de) Verschliessen einer flachtafelvorrichtung
DE10191882D2 (de) PMD-Kompensator
DE60130024D1 (de) Transformator mit einer niedrigen ausgangsspannung
DE50105252D1 (de) Hydrotransformator
DE10084998T1 (de) Styrene Polymer Composition
DE60126877D1 (de) D/A-Wandler
DE50304379D1 (de) Schalter mit einer bedienwippe
DE50104338D1 (de) Falzapparat mit einer Weiche
DE10194789T1 (de) Dämpfung
DE50211267D1 (de) Drehlagerung einer Tür
ITMI20001513A0 (it) Micomelanine a struttura polinaftoica
DK1154103T3 (da) Fladnøgle
DK200100180U3 (da) Nedgangsbrønd
DE50113818D1 (de) Programmgesteuerte einheit mit einer prefetch-einheit
DE10191764D2 (de) Aufzug mit einer Hohlspindel
IT251423Y1 (it) Cucina a sbalzo attrezzata
IT250045Y1 (it) Lenzuolo inferiore a collocazione plurima facilitata
FR2813224B3 (fr) Structure de clef

Legal Events

Date Code Title Description
8364 No opposition during term of opposition